Skip to main content
. 2014 Apr 22;8:503–511. doi: 10.2147/PPA.S38989

Figure 1.

Figure 1

PISCES study design.

Note: Reprinted with permission. © 2012 American Society of Clinical Oncology. All rights reserved. Escudier BJ, Porta C, Bono P. Patient preference between pazopanib and sunitinib: results of a randomized double-blind, placebo-controlled, cross-over study in patients with metastatic renal cell carcinoma – PISCES study, NCT 01064310. J Clin Oncol. 2012;30(Suppl 18):Abstr CRA4502.22

Abbreviations: CT, computed tomography; OD, once daily; SQLQ, Supplementary Quality of Life Questionnaire; FACIT-Fatigue, Functional Assessment of Chronic Illness Therapy for fatigue score.